John Lövrot

2.3k total citations · 2 hit papers
21 papers, 1.6k citations indexed

About

John Lövrot is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, John Lövrot has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in John Lövrot's work include Cancer Cells and Metastasis (12 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer Immunotherapy and Biomarkers (5 papers). John Lövrot is often cited by papers focused on Cancer Cells and Metastasis (12 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer Immunotherapy and Biomarkers (5 papers). John Lövrot collaborates with scholars based in Sweden, United States and Finland. John Lövrot's co-authors include Jonas Bergh, Theodoros Foukakis, Kristian Pietras, Matteo Bocci, Christer Larsson, Michael Bartoschek, Chris D. Madsen, Nikolay Oskolkov, Göran Karlsson and Mikael N.E. Sommarin and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

John Lövrot

19 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing

2018 561 citations Michael Bartoschek, Nikolay Oskolkov et al. Nature Communications profile →
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

2017 408 citations Asís Palazón, Petros A. Tyrakis et al. Cancer Cell profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
John Lövrot	923	714	566	466	220	21	1.6k
Chongbiao Huang	765 0.8×	824 1.2×	598 1.1×	439 0.9×	261 1.2×	49	1.7k
Guozhu Xie	829 0.9×	581 0.8×	365 0.6×	616 1.3×	192 0.9×	33	1.6k
Robert J. Norgard	1.1k 1.2×	1.1k 1.5×	670 1.2×	340 0.7×	204 0.9×	16	2.0k
Albert Santamaria‐Martínez	865 0.9×	710 1.0×	410 0.7×	198 0.4×	170 0.8×	20	1.5k
Guichun Huang	655 0.7×	959 1.3×	636 1.1×	279 0.6×	239 1.1×	53	1.7k
David Nittner	753 0.8×	1.1k 1.5×	657 1.2×	490 1.1×	264 1.2×	18	1.7k
Bin Shi	852 0.9×	1.2k 1.6×	606 1.1×	219 0.5×	271 1.2×	16	2.1k
Janna Paulsson	703 0.8×	748 1.0×	398 0.7×	217 0.5×	292 1.3×	21	1.5k
Min Hye Jang	1.0k 1.1×	610 0.9×	473 0.8×	303 0.7×	279 1.3×	42	1.7k
Stéphanie Dauvillier	942 1.0×	1.4k 1.9×	1.0k 1.8×	366 0.8×	182 0.8×	20	2.5k

Countries citing papers authored by John Lövrot

Since Specialization

Citations

This map shows the geographic impact of John Lövrot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lövrot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lövrot more than expected).

Fields of papers citing papers by John Lövrot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lövrot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lövrot. The network helps show where John Lövrot may publish in the future.

Co-authorship network of co-authors of John Lövrot

This figure shows the co-authorship network connecting the top 25 collaborators of John Lövrot. A scholar is included among the top collaborators of John Lövrot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lövrot. John Lövrot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kouvaraki, Maria A., Ioannis Zerdes, Emmanouil G. Sifakis, et al.. (2024). Prognostic and predictive implications of sterile alpha motif and HD domain‐containing protein 1 (SAMHD1) expression in breast cancer. International Journal of Cancer. 156(8). 1621–1633.

Chen, Xinsong, Emmanouil G. Sifakis, Stephanie Robertson, et al.. (2022). 1668P Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction. Annals of Oncology. 33. S1306–S1306. 1 indexed citations

Chen, Xinsong, Emmanouil G. Sifakis, Stephanie Robertson, et al.. (2022). Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction. Proceedings of the National Academy of Sciences. 120(1). e2209856120–e2209856120. 13 indexed citations

Matikas, Alexios, Ioannis Zerdes, John Lövrot, et al.. (2020). PD-1 protein and gene expression as prognostic factors in early breast cancer. ESMO Open. 5(6). e001032–e001032. 14 indexed citations

Sjöberg, Elin, Max Meyrath, Laura Milde, et al.. (2019). A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer. Clinical Cancer Research. 25(12). 3702–3717. 87 indexed citations

Matikas, Alexios, Ioannis Zerdes, John Lövrot, et al.. (2019). Prognostic Implications of PD-L1 Expression in Breast Cancer: Systematic Review and Meta-analysis of Immunohistochemistry and Pooled Analysis of Transcriptomic Data. Clinical Cancer Research. 25(18). 5717–5726. 73 indexed citations

Bartoschek, Michael, Nikolay Oskolkov, Matteo Bocci, et al.. (2018). Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nature Communications. 9(1). 5150–5150. 561 indexed citations breakdown →

Foukakis, Theodoros, John Lövrot, Alexios Matikas, et al.. (2018). Immune gene expression and response to chemotherapy in advanced breast cancer. British Journal of Cancer. 118(4). 480–488. 37 indexed citations

Alkodsi, Amjad, Una Kjällquist, Gustav Stålhammar, et al.. (2018). Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes. Journal of Clinical Investigation. 128(4). 1355–1370. 108 indexed citations

10.

Sjöberg, Elin, John Lövrot, Artur Mezheyeuski, et al.. (2018). A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis. British Journal of Cancer. 119(7). 840–846. 44 indexed citations

11.

Matikas, Alexios, John Lövrot, Mikael Eriksson, et al.. (2018). Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer. OncoImmunology. 7(9). e1466017–e1466017. 34 indexed citations

12.

Sim, Sarah C., et al.. (2018). Effect of CYP2C19 and CYP2D6 Genotype on Tamoxifen Treatment Outcome Indicates Endogenous and Exogenous Interplay. Pharmacogenomics. 19(13). 1027–1037. 10 indexed citations

13.

Rantalainen, Mattias, Gustav Stålhammar, John Lövrot, et al.. (2017). Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling. BMC Cancer. 17(1). 802–802. 12 indexed citations

14.

Palazón, Asís, Petros A. Tyrakis, David Macías, et al.. (2017). An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression. Cancer Cell. 32(5). 669–683.e5. 408 indexed citations breakdown →

15.

Ma, Ran, John Lövrot, Felix Haglund, et al.. (2017). Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells. JNCI Journal of the National Cancer Institute. 109(3). 1–14. 66 indexed citations

16.

Zerdes, Ioannis, Nikolaos Tsesmetzis, John Lövrot, et al.. (2017). Regulation of PD-L1 in breast cancer.. Journal of Clinical Oncology. 35(15_suppl). e23088–e23088.

17.

Cunha, Sara I., Matteo Bocci, John Lövrot, et al.. (2015). Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer. Cancer Research. 75(12). 2445–2456. 48 indexed citations

18.

Foukakis, Theodoros, John Lövrot, Linda S. Lindström, et al.. (2015). Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer. Molecular Oncology. 9(7). 1384–1391. 11 indexed citations

19.

Ma, Ran, John Lövrot, Lóránd Kis, et al.. (2015). mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells. Cancer Letters. 367(1). 76–87. 46 indexed citations

20.

Foukakis, Theodoros, John Lövrot, & Jonas Bergh. (2014). Thyroid hormone inactivation in gastrointestinal stromal tumors.. New England Journal of Medicine. 371(1). 84–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact